← Back to Search

Stepped Care Management for Lower Back Pain (SMART LBP Trial)

N/A
Waitlist Available
Led By Daniel I Rhon, PhD
Research Sponsored by Brooke Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Chief complaint of LBP which may be self-reported or identified by primary International Classification of Disease (ICD), 10th edition codes of LBP (M54.5, M54.9, S33.012), lumbar degenerative change (M51.36, M51.37, M48.06, M47.817), lumbar disc herniation/radiculitis (M54.16, M54.17, M51.26, M51.27, M54.3).
Age 18 - 65 years at the time of enrollment.
Must not have
Signs of serious or systemic pathology as a cause of LBP including spine fracture, neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.
Has received any lumbar spine surgery in the past year.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will study two possible treatments for chronic low back pain, physical therapy or Move 2 Health. If neither of these treatments work after six weeks, patients will then be randomized to receive either the addition of the other treatment or the MORE Mindfulness intervention.

Who is the study for?
This trial is for active duty military, reservists on active duty, their family members, or Tricare beneficiaries with chronic low back pain. Participants must be aged 18-65 and able to attend treatment sessions over a 16-week period. Exclusions include recent lumbar spine surgery, pending military discharge for medical reasons, serious causes of back pain like fractures or neoplasms, pregnancy, and certain treatments received in the past 6 months.
What is being tested?
The study tests two initial treatments for chronic low back pain: physical therapy or Move 2 Health (M2H). Those not improving after six weeks enter Phase II where they either add the other initial treatment they didn't receive or start MORE Mindfulness intervention. The process involves random assignment and participants are monitored for one year.
What are the potential side effects?
While specific side effects aren't listed here as it's more about management strategies than medications; potential side effects may include muscle soreness from physical therapy exercises and emotional discomfort when engaging in mindfulness practices if underlying psychological issues surface.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have lower back pain or a related condition.
Select...
I am between 18 and 65 years old.
Select...
I have had lower back pain for more than 3 months and it's been frequent in the last 6 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My lower back pain is not due to a serious condition like a fracture or cancer.
Select...
I have had surgery on my lower back in the last year.
Select...
I have seen specialists or had therapy for lower back pain in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PROMIS-Pain Interference Computer Adapted Test (PI-CAT)
Secondary study objectives
PROMIS Physical Function Computer Adapted Test (PF-CAT)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Phase II: MORE MindfulnessExperimental Treatment1 Intervention
Sequential Randomization: Participants randomized to receive mindfulness as a Phase II intervention will discontinue their Phase I treatment. The Mindfulness-Oriented Recovery Enhancement (MORE) treatment was designed specifically to address symptoms and underlying mechanisms of chronic pain in the military context and is led over 8 individual sessions.
Group II: Phase II: Combine PT & M2HExperimental Treatment2 Interventions
Sequential Randomization: Participants randomized to receive a combination of PT and M2H as a Phase II intervention will continue their Phase I treatment (either M2H or PT). The participant will begin the treatment component that was not part of their Phase I intervention.
Group III: Phase I: Physical Therapy (PT)Experimental Treatment1 Intervention
Initial Randomization: The initial PT treatment session will occur within 7 days of enrollment in the study. Precise dosage (i.e, number of PT sessions) will be at the discretion of the physical therapist directing the participant's care, up to a maximum of 2-3 sessions per week over the 6-week Phase I treatment period.
Group IV: Phase I: Move to Health (M2H)Experimental Treatment1 Intervention
Initial Randomization: M2H is a key component of Army Medicine's "System for Health", along with the Performance Triad. It is a person-centered, holistic, and experience-centric approach to promoting healthy behaviors (nutrition, physical activity, sleep, instrinsic factors, extrinsic factors). Precise dosage (i.e, number of M2H sessions) will be at the discretion of the health coaches. Sessions may be delivered in-person or utilize technology including text messaging, telephone, e-mail, video chat, app-based self-management etc.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Therapy
2020
Completed Phase 4
~1280

Find a Location

Who is running the clinical trial?

University of UtahOTHER
1,147 Previous Clinical Trials
1,698,771 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
867 Previous Clinical Trials
674,121 Total Patients Enrolled
Madigan Army Medical CenterFED
48 Previous Clinical Trials
16,988 Total Patients Enrolled
Tripler Army Medical CenterFED
20 Previous Clinical Trials
26,799 Total Patients Enrolled
59th Medical WingFED
40 Previous Clinical Trials
11,800 Total Patients Enrolled
Brooke Army Medical CenterLead Sponsor
129 Previous Clinical Trials
26,787 Total Patients Enrolled
Daniel I Rhon, PhDPrincipal InvestigatorBrooke Army Medical Center
Julie M Fritz, PhDPrincipal InvestigatorUniversity of Utah
3 Previous Clinical Trials
436 Total Patients Enrolled
Daniel I Rhon, DScPrincipal InvestigatorBrooke Army Medical Center
2 Previous Clinical Trials
572 Total Patients Enrolled

Media Library

Move 2 Health (M2H) Clinical Trial Eligibility Overview. Trial Name: NCT04172038 — N/A
Lower Back Pain Research Study Groups: Phase I: Physical Therapy (PT), Phase II: MORE Mindfulness, Phase II: Combine PT & M2H, Phase I: Move to Health (M2H)
Lower Back Pain Clinical Trial 2023: Move 2 Health (M2H) Highlights & Side Effects. Trial Name: NCT04172038 — N/A
Move 2 Health (M2H) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04172038 — N/A
~40 spots leftby Apr 2025